Corrigendum to 'Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis: The TERABIT study' [Bone 160 (2022) 116416]

Autor:	Ko Chiba, Narihiro Okazaki, Ayako Kurogi, Tsuyoshi Watanabe, Ai Mori, Nobuhiko Suzuki, Koichi Adachi, Makoto Era, Kazuaki Yokota, Takuma Inoue, Yoshihiro Yabe, Keizo Furukawa, Choko Kondo, Keiichi Tsuda, Shingo Ota, Yusaku Isobe, Satsuki Miyazaki, Shimpei Morimoto, Shuntaro Sato, Sawako Nakashima, Shigeki Tashiro, Akihiko Yonekura, Masato Tomita, Makoto Osaki
Rok vydání:	2022
Předmět:	Histology Physiology Endocrinology Diabetes and Metabolism
Zdroj:	Bone. 162:116484
ISSN:	8756-3282
DOI:	10.1016/j.bone.2022.116484
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5c583b15fd61d9c820d1aeb234713528 https://doi.org/10.1016/j.bone.2022.116484 Zobrazit plný text záznamu Full Text from ScienceDirect